• SENSEX 81,087.69
    -97.89 (--0.12%)
  • BANKNIFTY 55,617.60
    -344.35 (--0.62%)
  • Tata Motors
    647.20 542.55(%)
  • Axis Bank
    1,060.20 934.00(%)
  • Vimta Labs
    677.30 235.00(%)
  • GE Vernova T&D
    2,871.15 2,871.15(%)
  • Netweb Technol.
    2,299.15 3,060.00(%)
  • Suzlon Energy
    66.80 86.04(%)
  • Kaynes Tech
    6,483.00 7,824.95(%)
  • M & M
    3,117.25 2,360.45(%)
  • PNB Housing
    803.30 746.10(%)
  • Waaree Energies
    3,163.55 3,740.75(%)
  • HDFC Bank
    2,010.00 1,593.20(%)
  • Jayaswal Neco
    48.32 26.06(%)
  • Skipper
    548.00 665.00(%)
  • Shree Refrigerat
    177.70 177.70(%)
  • Timex Group
    244.75 289.90(%)
  • Hind. Unilever
    2,728.10 3,034.50(%)
  • TCS
    3,000.00 3,000.00(%)
  • Ceinsys Tech
    1,750.85 538.20(%)
  • Swiggy
    386.25 297.00(%)
  • KIOCL
    374.20 461.35(%)
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison
Overview
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison

IOL Chemicals & Pharmaceuticals Ltd Pharmaceuticals - Indian - Bulk Drugs & Formln

  • Indian Private
  • BSE Code : 1973.0
  • ISIN : INE485C01029
100.17 -3 (-2.90%)
  • As on 02 Aug 2025 (EOD)

  • Today’s Low

    99.58

  • Today’s High

    103.34

  • Open

    103.00

  • Perv Close

    103.16

  • 52W Low

    57.50

  • 52W High

    107.54

Key Indicators

  • P/E(TTM)

    29.16

  • Mar.Cap (₹Cr.)

    2,940.27

  • Div & Yield %

    0.80

  • Book Value(₹)

    57.49

  • Debt-Equity Ratio

    -2.90

  • AGM Date

    01-Aug-2025

  • EPS

    3.44

  • P/E Ratio

    29.16

Financials Ratios

  • Debt-Equity Ratio

    0.04

  • Mar.Cap (₹Cr.)

    2,940.27

  • RONW (%)

    8.62

  • ROCE (%)

    12.21

Score Board

  • Equity (₹ in Cr.)

    58.71

  • BV (₹)

    57.50

  • Sales( ₹ in Cr.)

    2,079.21

  • NP (in Cr.)

    101.13

  • NP Var(%)

    -25.0

  • Div%

    40.0

  • CPS (₹)

    5.90

  • EPS (₹)

    3.40

  • Traded Value (₹ in Lakhs)

    2,944.08

  • 52 Week High

    107.54

  • 52 Week Low

    57.50

  • Price BSE

    100.0

  • Price NSE

    100.00

  • Market Capital( in Cr.)

    2,944.08

  • P/C Ratio

    17.00

  • P/E Ratio

    29.00

  • Price Vs.BV

    3.40

View More
Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)
Particulars(INCOME) 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar
INCOME :            
Sales Turnover 2,079.21 2,132.79 2,217.11 2,184.02 1,966.98 1,894.47
Excise Duty 0.00 0.00 0.00 0.00 0.00 0.00
Net Sales 2,079.21 2,132.79 2,217.11 2,184.02 1,966.98 1,894.47
Other Income 22.40 30.07 25.57 32.04 24.30 16.02
Stock Adjustments -33.51 38.25 18.20 52.30 17.11 -20.96
Total Income 2,068.10 2,201.11 2,260.88 2,268.36 2,008.39 1,889.53
EXPENDITURE :            
Raw Materials 1,358.34 1,435.20 1,565.29 1,622.81 1,119.95 1,044.05
Power and Fuel Cost 114.93 149.05 131.98 78.18 51.46 65.12
Employee Cost 216.57 201.02 168.21 141.30 115.55 97.20
Other Manufacturing Expenses 47.39 47.67 43.07 36.86 28.13 28.37
Selling and Administration Expenses 70.29 60.24 68.37 71.96 55.26 51.31
Miscellaneous Expenses 36.01 46.34 31.87 42.86 21.90 13.58
Employee Benefit Expenses 216.57 201.02 168.21 141.30 115.55 97.20
Less: Preoperative Expenditure 0.00 0.00 0.00 0.00 0.00 0.00
Total Expenses 1,843.53 1,939.52 2,008.79 1,993.97 1,392.25 1,299.63
Operating Profit 224.57 261.59 252.09 274.39 616.14 589.90
Interest 14.76 16.10 16.47 8.29 5.83 20.93
Gross Profit 209.81 245.49 235.62 266.10 610.31 568.97
Depreciation 71.92 62.85 46.13 43.26 38.92 35.73
Profit Before Tax 137.89 182.64 189.49 222.84 571.39 533.24
Current Tax 24.74 37.01 46.26 57.01 145.55 170.90
Fringe Benefit tax 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax 12.15 10.21 3.25 0.17 -18.72 1.05
Reported Net Profit 101.00 135.42 139.98 165.66 444.56 361.29
Extraordinary Items -0.13 0.07 -0.27 -11.05 -0.05 0.00
Adjusted Net Profit 101.13 135.35 140.25 176.71 444.61 361.29
Adjustment below Net Profit 0.00 0.00 0.00 0.00 0.00 0.00
P & L Balance brought forward 1,324.30 1,218.23 1,101.75 971.31 550.23 209.51
Statutory Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
Appropriations 23.48 29.35 23.50 35.22 23.48 20.57
P & L Balance carried down 1,401.82 1,324.30 1,218.23 1,101.75 971.31 550.23
Dividend 23.48 29.35 23.50 35.22 23.48 17.07
Preference Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Equity Dividend (%) 40.00 50.00 40.00 40.00 60.00 30.00
Dividend Per Share(Rs) 0.80 5.00 4.00 4.00 6.00 3.00
Earnings Per Share-Unit Curr 3.44 23.07 23.84 28.22 75.72 63.51
Earnings Per Share(Adj)-Unit Curr 3.44 4.61 4.77 5.64 15.14 12.70
Book Value 57.48 274.46 256.61 236.80 214.69 141.36
Book Value(Adj)-Unit Curr 57.48 54.89 51.32 47.36 42.94 28.27

Shareholding Pattern

  • Promoter Group

    52.62%

  • Public Share Holding

    47.38%

Category of Shareholder No of Shares % Holdings Demat Shares Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate 0 0.00 0 0
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 0 0.00 0 0
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 0 0.00 0 0
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group) 0 0.00 0 0
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 0 0.00 0 0
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 5,984,825 2.04 5,984,825 2
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 0 0.00 0 0
Others 148,478,255 50.58 148,478,255 3
Sub Total 154,463,080 52.62 154,463,080 5
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State) 0 0.00 0 0
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 0 0.00 0 0
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 7,610,257 2.59 7,610,257 49
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 0 0.00 0 0
Mutual Funds / UTI 55,507 0.02 4,507 6
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 11,555 0.00 11,555 2
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 7,677,319 2.62 7,626,319 57
2] Non Institution
Bodies Corporate 32,824,832 11.18 32,809,332 389
Clearing Members 503,327 0.17 503,327 29
Directors of their Relatives 0 0.00 0 0
Employees 48,436 0.02 48,436 88
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 4,987,437 1.70 4,987,437 1,888
Foreign Non Institution Other 0 0.00 0 0
Hindu Undivided Families 3,888,854 1.32 3,888,854 2,139
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 12,980,618 4.42 12,980,618 44
Individuals holding nominal share capital up to Rs. 1 lakh 75,731,519 25.80 73,530,809 120,354
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 6,135 0.00 6,135 3
Others 27,000 0.01 27,000 1
Sub Total 131,387,111 44.76 129,170,901 124,978
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 0 0.00 0 0
Total Shares held by Custodians and against which Depository Receipts have been issued 0 0.00 0 0
Grand Total ( A + B + C ) 293,527,510 100.00 291,260,300 125,040

Company Background

IOL Chemicals & Pharmaceuticals LtdPharmaceuticals - Indian - Bulk Drugs & Formln

  • IOL Chemicals & Pharmaceuticals Ltd
  • BSE Code : 1973.0
  • ISIN : INE485C01029

  • Incorporation Year

    1986

  • Registered Office

    Trident Complex
    Raikot Road Barnala, Sangrur,
    Punjab-148101

  • Telephone

    91-01679-244701-07

  • FAX

    91-01679-244708

  • Chairman

    Rajender Mohan Malla

  • Managing Director

    Varinder Gupta

  • Company Secretary

    Abhay Raj Singh

  • Auditor

    Ashwani & Associates

  • Face Value

    2

  • Listing

    NSE

  • Registrar

    Alankit Assignments Ltd
    Alankit Heights ,
    1E/13 Jhandewalan Ex,
    Mumbai - New Delhi-110055

IOL Chemicals & Pharmaceuticals Ltd Peer Comparison

Profit & Loss
Financial Ratios
Balance Sheet
Select Company Name LTP (₹) Revenue Sales P/E Ratio ROCE %
IOL Chemicals 100.30 2,101.61 2,079.21 29.16 8.82
Abbott India 33,676.00 6,684.73 6,409.15 50.59 44.95
Astrazeneca Phar 8,893.15 1,756.92 1,716.29 192.08 32.94
P & G Health Ltd 6,199.70 1,166.89 1,151.26 40.97 39.76
Glaxosmi. Pharma 2,933.90 3,866.05 3,723.49 52.76 58.72
Cipla 1,501.20 20,029.57 19,044.85 22.44 21.40
Amrutanjan Healt 676.35 437.58 421.23 38.47 20.84
Guj. Themis Bio. 371.85 174.19 169.82 90.92 44.82
Fermenta Biotec. 362.00 442.21 430.53 15.76 17.61
Bliss GVS Pharma 173.70 703.42 667.20 25.96 9.16
Ambalal Sarabhai 32.97 19.33 4.04 30.53 2.10